Open original FDA record ↗Recall record
- FDA identifier
- Z-2477-2025
- Company in FDA record
- CareFusion 303, Inc.
- FDA classification date
- Aug 28, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Antivirus software was not consistently installed on impacted devices during the implementation process.
Source facts
- Action
- On 05/08/2025, the firm sent via mail and email an "URGENT MEDICAL DEVICE PRODUCT CORRECTION" Letter informing customers of two issues. For this recall the issue pertains to technicians failing to install (ESET) antivirus software on affected devices. This can potentially result in a malicious actor that could exploit a cybersecurity weakness on a device that is configured without antivirus protection within a hospital network. Customer are instructed and/or informed: For Clinical Users: -to utilize user facility policies and procedures for cybersecurity issues or disaster recovery. -to remove devices from network and continue to use operational devices in critical override per the BD Pyxis" MedStation" ES user guide DME 10000430667, version 00 (pages 74-75). For IT, Safety and Security: -Firewall Protection - The hospital firewall can block vulnerable ports. -Limit physical access to only authorized personnel. -Tightly control management of system passwords provided to authorized users. -Monitor and log network traffic attempting to reach the affected products for suspicious activity. -Isolate affected products in a secure VLAN or behind firewalls with restricted access that only permits communication with trusted hosts in other networks when needed. -Physical security - Manage who can access network or server rooms to reduce cyberattack or data breach risks. -Secure user access implement secure user passwords and/or biometric logins at the application level. -Regular database backups (ES devices only). -Additional Security layers - There are other layers of security still in place to mitigate potential malicious activity on ES devices such as secure Operating System passwords, database and file encryption, and secure user passwords / biometric logins at the application level. For questions: BD Remediation Support Phone: 1-866-583-8783 Phone Hours: 5:00am PST to 4:00pm PST (8:00am ET to 7:00pm ET) Monday - Friday Recall Customer Response Forms - email: BDRC22
- Initiated
- 2025-05-08
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - U.S Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MP, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY. The countries of United Arab Emirates, Argentina, Australia, Belgium, Bahrain, Bermuda, Brazil, Bahamas, Canada, Switzerland, Germany, Egypt, Finland, France, United Kingdom, Hong Kong, Indonesia, Ireland, India, Italy, Jordan, Lebanon, Morocco, Mexico, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, Thailand, Greece, Oman, and Taiwan.
- Recall number
- Z-2477-2025
- Recall status
- Open, Classified
- CDRH record ID
- 213001
- FDA classified
- 2025-08-28
- Recall event number
- 96477